TRHC Featured in Next Avenue’s Why COVID-19 Could Pose New Medication Risks

Why COVID-19 Could Pose New Medication Risks Next Avenue By Michele Cohen Marill December 1, 2020   It’s common for older adults to take multiple medications, whether they’re for easing pain, lowering blood pressure or cholesterol or treating a chronic condition. Yet the COVID-19 pandemic has amplified concerns about polypharmacy – regularly taking five or more prescription drugs. Some prescriptions have side effects, such as dizziness, that can be particularly dangerous for older people; others... Read More

Regence and TRHC Partner on COVID-19 Virtual Clinical Trial to Assess Proposed Treatment Risks

Moorestown, NJ, June 9, 2020 – Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19. The trial examines de-identified medical information for approximately 500,000 Regence health plan members across multiple lines of business. Regence is a family of health plans in Oregon, Idaho, Utah and select counties... Read More